Non-Clinical Health & Environmental Safety Studies

🌱 Visnova Insights: Ensuring Safety Beyond the Clinic – The Role of Non-Clinical Health & Environmental Safety Studies

📘 Introduction

In pharmaceutical and agrochemical research, non-clinical health and environmental safety studies are essential. They ensure that new drugs and chemicals are safe for both human and environmental health—before they ever reach clinical trials. These studies follow Good Laboratory Practice (GLP) to guarantee scientific accuracy and regulatory compliance.


🔬 Table 1: Overview of Non-Clinical Safety Studies

Purpose

Examples

Outcome/Use

Identify toxic effects

Acute, sub-chronic, chronic toxicity tests

Determine organ-specific toxicity

Establish exposure limits

Dose-response studies

Identify NOAEL (No-Observed-Adverse-Effect Level)

Study metabolism and kinetics

ADME studies (Absorption, Distribution, Metabolism, Excretion)

Understand drug movement and breakdown

Reproductive & developmental toxicity

Fertility, embryo-fetal development studies

Evaluate impact on reproduction

Genetic toxicity

Ames test, Micronucleus test

Detect potential mutagenic properties


🌍 Table 2: Types of Environmental Safety Studies

Study Type

Key Focus

Measured Parameters

Significance

Environmental Fate

Degradation in soil, water, air

DT50, DT90, Half-life

Predicts persistence in environment

Ecotoxicology

Effect on fish, daphnia, algae

LC50, EC50, NOEC

Assesses toxicity to non-target organisms

Bioaccumulation

Chemical accumulation in living tissues

BAF, BCF

Estimates long-term ecological risk

Mobility in Soil

Movement of substance through soil

Koc (Adsorption Coefficient)

Evaluates groundwater contamination risk


🏛 Table 3: GLP Regulatory Compliance Across Regions

Region

Regulatory Authority

GLP Guidelines Followed

Applicable Sectors

USA

US FDA, US EPA

21 CFR Part 58, FIFRA GLP Rules

Pharma, Environment, Pesticides

Europe

EMA, ECHA

OECD Principles of GLP

Pharma, Agrochemicals

India

NGCMA (DSIR), MoEFCC

OECD-GLP via NABL recognition

Pharma, Agrochemicals, Environment

Japan

PMDA, MHLW

OECD GLP + Local Ministry Guidelines

Pharmaceuticals


🧩 Table 4: Visnova’s Support for Non-Clinical Studies

Area of Expertise

Services Provided

Target Clients

Lab Setup & Infrastructure

Layout planning, Equipment selection, Documentation

New CROs, QA Units

GLP Training

SOP writing, QA/QC training, GLP documentation practices

Analysts, Study Directors, QA personnel

Regulatory Documentation

Study plan design, Report formatting, Archival guidance

CROs, Regulatory teams

Mock Audits & Prechecks

Compliance review, Gap analysis, Remedial actions

Labs seeking NABL/OECD certification


📣 Connect with Visnova

For consultations, training, or lab setup in non-clinical and environmental safety testing:

📧 Email: poornachandrashetty@visnovacom.com
🌐 Website: Coming Soon!

 


Comments

Popular posts from this blog

Organization Process

What Are Complex Generics?

GLP-CRO labs